Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.

Lindsay SL, Johnstone SA, McGrath MA, Mallinson D, Barnett SC.

Stem Cell Reports. 2016 May 10;6(5):729-742. doi: 10.1016/j.stemcr.2016.03.009. Epub 2016 Apr 21.

2.

Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces.

Johnstone SA, Liley M, Dalby MJ, Barnett SC.

Acta Biomater. 2015 Feb;13:266-76. doi: 10.1016/j.actbio.2014.11.027. Epub 2014 Nov 21.

PMID:
25463488
3.

Human mesenchymal stem cells isolated from olfactory biopsies but not bone enhance CNS myelination in vitro.

Lindsay SL, Johnstone SA, Mountford JC, Sheikh S, Allan DB, Clark L, Barnett SC.

Glia. 2013 Mar;61(3):368-82. doi: 10.1002/glia.22440. Epub 2012 Dec 22.

PMID:
23281012
4.

Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo.

Tardi PG, Dos Santos N, Harasym TO, Johnstone SA, Zisman N, Tsang AW, Bermudes DG, Mayer LD.

Mol Cancer Ther. 2009 Aug;8(8):2266-75. doi: 10.1158/1535-7163.MCT-09-0243. Epub 2009 Aug 11.

5.

Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates.

Ansell SM, Johnstone SA, Tardi PG, Lo L, Xie S, Shu Y, Harasym TO, Harasym NL, Williams L, Bermudes D, Liboiron BD, Saad W, Prud'homme RK, Mayer LD.

J Med Chem. 2008 Jun 12;51(11):3288-96. doi: 10.1021/jm800002y. Epub 2008 May 9.

PMID:
18465845
6.

Usefulness of muscle denervation as an MRI sign of peripheral nerve pathology.

Lisle DA, Johnstone SA.

Australas Radiol. 2007 Dec;51(6):516-26. Review.

PMID:
17958685
7.
8.

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.

Mayer LD, Harasym TO, Tardi PG, Harasym NL, Shew CR, Johnstone SA, Ramsay EC, Bally MB, Janoff AS.

Mol Cancer Ther. 2006 Jul;5(7):1854-63.

9.

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).

Allen C, Dos Santos N, Gallagher R, Chiu GN, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS, Bally MB.

Biosci Rep. 2002 Apr;22(2):225-50. Review.

PMID:
12428902
10.

Quality of life after lung cancer surgery: a forgotten outcome measure.

Chen JC, Johnstone SA.

Chest. 2002 Jul;122(1):4-5. No abstract available.

PMID:
12114328
11.
13.

Regulation of annexin I-dependent aggregation of phospholipid vesicles by protein kinase C.

Johnstone SA, Hubaishy I, Waisman DM.

Biochem J. 1993 Sep 15;294 ( Pt 3):801-7.

14.

Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein.

Johnstone SA, Hubaishy I, Waisman DM.

J Biol Chem. 1992 Dec 25;267(36):25976-81.

PMID:
1464610
15.

Enolase is present at the centrosome of HeLa cells.

Johnstone SA, Waisman DM, Rattner JB.

Exp Cell Res. 1992 Oct;202(2):458-63.

PMID:
1397098
16.

Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase.

Rattner JB, Martin L, Waisman DM, Johnstone SA, Fritzler MJ.

J Immunol. 1991 Apr 1;146(7):2341-4.

PMID:
1706394
17.

Membrane glycoprotein and surface free energy changes in hypoxic fibroblast cells.

Johnstone SA, Schurch S, McIver DJ, Jacobson EA, Tustanoff ER.

Biochim Biophys Acta. 1985 May 14;815(2):159-69.

PMID:
3995020

Supplemental Content

Loading ...
Support Center